Sigma Planning Corp’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,278
Closed -$14.8K 1235
2024
Q2
$14.8K Sell
2,278
-901
-28% -$6.29K ﹤0.01% 1177
2024
Q1
$23.8K Buy
3,179
+870
+38% +$7.26K ﹤0.01% 1206
2023
Q4
$19.4K Sell
2,309
-2,790
-55% -$17.6K ﹤0.01% 835
2023
Q3
$29.9K Buy
5,099
+605
+13% +$5.3K ﹤0.01% 1170
2023
Q2
$48.1K Sell
4,494
-106
-2% -$716 ﹤0.01% 1172
2023
Q1
$29K Buy
4,600
+64
+1% +$476 ﹤0.01% 1275
2022
Q4
$31.8K Hold
4,536
﹤0.01% 1237
2022
Q3
$38K Buy
4,536
+1,355
+43% +$13.1K ﹤0.01% 1229
2022
Q2
$24K Buy
3,181
+40
+1% +$391 ﹤0.01% 1268
2022
Q1
$41K Buy
3,141
+1,470
+88% +$19.8K ﹤0.01% 1339
2021
Q4
$27K Sell
1,671
-340
-17% -$7.71K ﹤0.01% 1372
2021
Q3
$53K Sell
2,011
-500
-20% -$14.6K ﹤0.01% 1345
2021
Q2
$86K Sell
2,511
-40
-2% -$1.57K ﹤0.01% 1368
2021
Q1
$129K Buy
2,551
+1,350
+112% +$83.5K ﹤0.01% 1268
2020
Q4
$56K Buy
+1,201
New +$42.3K ﹤0.01% 1174

Other funds holding EVGN

Sigma Planning Corp's EVGN Position: Q3 2024 in Review

Sigma Planning Corp sold out of Evogene (EVGN) in Q3 2024, closing a stake of 2,278 shares — an estimated $14.8K sold.

Sigma Planning Corp first reported a position in EVGN in Q4 2020 and held it in 15 quarters. The position peaked at $129K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Sigma Planning Corp reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Sigma Planning Corp sold 2,278 Evogene shares in Q3 2024, an estimated $14.8K.
  • Sigma Planning Corp first reported a position in Evogene in Q4 2020 and held it in 15 quarters.
  • Sigma Planning Corp's Evogene position peaked at $129K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Sigma Planning Corp's 13F filing for Q3 2024, filed 4 Nov 2024.